Researcher biography

Dr Adam Hagg is a post-doctoral researcher in the School of Biomedical Sciences at The University of Queensland. He received his PhD from Monash University in 2021, conducting his research across the Baker Heart and Diabetes Institute and the Departments of Physiology at Monash University and The University of Melbourne. Adam’s PhD studies concentrated on identifying a novel role for the Bone Morphogenetic Protein signalling pathway in regulating skeletal muscle mass and neuromuscular remodeling in the setting of advanced cancer.

Adam’s current research interests include identifying novel cellular mechanisms that contribute to whole-body dysfunction including skeletal muscle wasting, neuromuscular dysfunction and metabolic disease. Adam’s work builds on his experience in using recombinant viral vector technologies in pre-clinical models to manipulate cellular mechanisms (including the TGF-beta network) with the ultimate aim of identifying therapeutic strategies for conditions such as cancer cachexia, obesity and neuromuscular diseases.